NZ622781B2 - Disinfectant compositions and uses thereof - Google Patents
Disinfectant compositions and uses thereof Download PDFInfo
- Publication number
- NZ622781B2 NZ622781B2 NZ622781A NZ62278112A NZ622781B2 NZ 622781 B2 NZ622781 B2 NZ 622781B2 NZ 622781 A NZ622781 A NZ 622781A NZ 62278112 A NZ62278112 A NZ 62278112A NZ 622781 B2 NZ622781 B2 NZ 622781B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- composition
- disinfectant
- disinfecting
- disinfectant composition
- surface against
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 116
- 230000000249 desinfective Effects 0.000 title claims abstract description 83
- 241000894006 Bacteria Species 0.000 claims abstract description 33
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 28
- 229940076185 Staphylococcus aureus Drugs 0.000 claims abstract description 27
- 241000191967 Staphylococcus aureus Species 0.000 claims abstract description 27
- 235000002961 Aloe barbadensis Nutrition 0.000 claims abstract description 25
- 240000005513 Aloe vera Species 0.000 claims abstract description 25
- FOIXSVOLVBLSDH-UHFFFAOYSA-N silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 claims abstract description 23
- 206010041925 Staphylococcal infection Diseases 0.000 claims abstract description 15
- 239000000758 substrate Substances 0.000 claims description 15
- 230000001603 reducing Effects 0.000 claims description 12
- 238000006722 reduction reaction Methods 0.000 claims description 12
- 241000700605 Viruses Species 0.000 claims description 10
- 241000588724 Escherichia coli Species 0.000 claims description 9
- -1 wool Substances 0.000 claims description 8
- 241000233866 Fungi Species 0.000 claims description 7
- 241000195493 Cryptophyta Species 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 241000193163 Clostridioides difficile Species 0.000 claims description 5
- 241000588767 Proteus vulgaris Species 0.000 claims description 5
- 229940007042 Proteus vulgaris Drugs 0.000 claims description 5
- 241000589516 Pseudomonas Species 0.000 claims description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 5
- 239000010452 phosphate Substances 0.000 claims description 5
- 229910001220 stainless steel Inorganic materials 0.000 claims description 5
- 239000010935 stainless steel Substances 0.000 claims description 5
- 241001116389 Aloe Species 0.000 claims description 4
- 241000194033 Enterococcus Species 0.000 claims description 4
- 241001138501 Salmonella enterica Species 0.000 claims description 4
- 229960003165 Vancomycin Drugs 0.000 claims description 4
- 108010059993 Vancomycin Proteins 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 3
- 239000000919 ceramic Substances 0.000 claims description 2
- 239000011521 glass Substances 0.000 claims description 2
- 239000004033 plastic Substances 0.000 claims description 2
- 229920003023 plastic Polymers 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 2
- MYPYJXKWCTUITO-LYRMYLQWSA-N VANCOMYCIN Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 claims 1
- 210000002268 Wool Anatomy 0.000 claims 1
- 150000002500 ions Chemical class 0.000 abstract 1
- 210000004027 cells Anatomy 0.000 description 20
- 230000000845 anti-microbial Effects 0.000 description 16
- 239000000499 gel Substances 0.000 description 16
- 238000011081 inoculation Methods 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 244000052616 bacterial pathogens Species 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 239000002054 inoculum Substances 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 239000002253 acid Substances 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 239000004332 silver Substances 0.000 description 5
- 229910052709 silver Inorganic materials 0.000 description 5
- OSVXSBDYLRYLIG-UHFFFAOYSA-N Chlorine dioxide Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 description 4
- 239000000645 desinfectant Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000012149 noodles Nutrition 0.000 description 4
- HWGNBUXHKFFFIH-UHFFFAOYSA-I pentasodium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O HWGNBUXHKFFFIH-UHFFFAOYSA-I 0.000 description 4
- 235000021317 phosphate Nutrition 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- 239000001187 sodium carbonate Substances 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 235000017550 sodium carbonate Nutrition 0.000 description 4
- 235000019832 sodium triphosphate Nutrition 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 3
- 230000000844 anti-bacterial Effects 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 230000002045 lasting Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000002688 persistence Effects 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- MYPYJXKWCTUITO-LYRMYLQWSA-O vancomycin(1+) Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C([O-])=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)[NH2+]C)[C@H]1C[C@](C)([NH3+])[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-O 0.000 description 3
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 2
- 239000004155 Chlorine dioxide Substances 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N Diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
- 101700015827 FYPP3 Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N Hypochlorite Chemical class Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 2
- 229920000715 Mucilage Polymers 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- 206010039447 Salmonellosis Diseases 0.000 description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N Sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
- 239000005708 Sodium hypochlorite Substances 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 206010048038 Wound infection Diseases 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 239000000980 acid dye Substances 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000001580 bacterial Effects 0.000 description 2
- 230000003115 biocidal Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 235000019398 chlorine dioxide Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 201000009910 diseases by infectious agent Diseases 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 229960003085 meticillin Drugs 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000006011 modification reaction Methods 0.000 description 2
- QDHHCQZDFGDHMP-UHFFFAOYSA-N monochloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- 101700004450 phpP Proteins 0.000 description 2
- 239000001967 plate count agar Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 210000001519 tissues Anatomy 0.000 description 2
- OAYXUHPQHDHDDZ-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethanol Chemical compound CCCCOCCOCCO OAYXUHPQHDHDDZ-UHFFFAOYSA-N 0.000 description 1
- WBIQQQGBSDOWNP-UHFFFAOYSA-N 2-Dodecylbenzenesulfonic acid Chemical compound CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O WBIQQQGBSDOWNP-UHFFFAOYSA-N 0.000 description 1
- 241000588626 Acinetobacter baumannii Species 0.000 description 1
- 229940064005 Antibiotic throat preparations Drugs 0.000 description 1
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 1
- 229940042052 Antibiotics for systemic use Drugs 0.000 description 1
- 229940042786 Antitubercular Antibiotics Drugs 0.000 description 1
- 241001226615 Asphodelus albus Species 0.000 description 1
- 229940075612 Bacillus cereus Drugs 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 206010003997 Bacteraemia Diseases 0.000 description 1
- 229960000686 Benzalkonium Chloride Drugs 0.000 description 1
- 210000000988 Bone and Bones Anatomy 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 102100019451 CD80 Human genes 0.000 description 1
- 101700080477 CD80 Proteins 0.000 description 1
- 210000000170 Cell Membrane Anatomy 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 206010067822 Community acquired infection Diseases 0.000 description 1
- 241000304911 Crassula falcata Species 0.000 description 1
- 239000004150 EU approved colour Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014665 Endocarditis Diseases 0.000 description 1
- 241000194031 Enterococcus faecium Species 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 229940093922 Gynecological Antibiotics Drugs 0.000 description 1
- 241000700588 Human alphaherpesvirus 1 Species 0.000 description 1
- 210000000987 Immune System Anatomy 0.000 description 1
- 229940045505 Klebsiella pneumoniae Drugs 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- AOMUHOFOVNGZAN-UHFFFAOYSA-N Lauroyl diethanolamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 1
- 241000186781 Listeria Species 0.000 description 1
- 240000002262 Litsea cubeba Species 0.000 description 1
- 235000012854 Litsea cubeba Nutrition 0.000 description 1
- MQYXUWHLBZFQQO-CWFQSGEHSA-N Lupenol Natural products C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@H](C(=C)C)[C@H]5[C@H]4CC[C@@H]3[C@]21C MQYXUWHLBZFQQO-CWFQSGEHSA-N 0.000 description 1
- MQYXUWHLBZFQQO-QGTGJCAVSA-N Lupeol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C MQYXUWHLBZFQQO-QGTGJCAVSA-N 0.000 description 1
- 241001263478 Norovirus Species 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 239000004698 Polyethylene (PE) Substances 0.000 description 1
- 229940055023 Pseudomonas aeruginosa Drugs 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 241000702670 Rotavirus Species 0.000 description 1
- 210000003491 Skin Anatomy 0.000 description 1
- 206010040872 Skin infection Diseases 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 1
- 206010044248 Toxic shock syndrome Diseases 0.000 description 1
- 231100000650 Toxic shock syndrome Toxicity 0.000 description 1
- 241001045770 Trichophyton mentagrophytes Species 0.000 description 1
- 241000681094 Zingel asper Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000003868 ammonium compounds Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000111 anti-oxidant Effects 0.000 description 1
- 230000003078 antioxidant Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002708 enhancing Effects 0.000 description 1
- 230000003203 everyday Effects 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000002209 hydrophobic Effects 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 200000000003 influenza A Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940079866 intestinal antibiotics Drugs 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 230000002934 lysing Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 239000002609 media Substances 0.000 description 1
- 201000009906 meningitis Diseases 0.000 description 1
- 230000002503 metabolic Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 1
- 229940006093 opthalmologic coloring agents Diagnostic Drugs 0.000 description 1
- 230000001717 pathogenic Effects 0.000 description 1
- 244000052769 pathogens Species 0.000 description 1
- SCKXCAADGDQQCS-UHFFFAOYSA-N performic acid Chemical compound OOC=O SCKXCAADGDQQCS-UHFFFAOYSA-N 0.000 description 1
- 230000002085 persistent Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 235000013613 poultry product Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000000241 respiratory Effects 0.000 description 1
- 230000000717 retained Effects 0.000 description 1
- 238000011012 sanitization Methods 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 229940057950 sodium laureth sulfate Drugs 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002195 synergetic Effects 0.000 description 1
- AYEKOFBPNLCAJY-UHFFFAOYSA-O thiamine pyrophosphate Chemical compound CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N AYEKOFBPNLCAJY-UHFFFAOYSA-O 0.000 description 1
- 235000008170 thiamine pyrophosphate Nutrition 0.000 description 1
- 125000004149 thio group Chemical group *S* 0.000 description 1
- 230000001052 transient Effects 0.000 description 1
- 238000004642 transportation engineering Methods 0.000 description 1
- 241000007181 unidentified human coronavirus Species 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N2300/00—Combinations or mixtures of active ingredients covered by classes A01N27/00 - A01N65/48 with other active or formulation relevant ingredients, e.g. specific carrier materials or surfactants, covered by classes A01N25/00 - A01N65/48
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/24—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing ingredients to enhance the sticking of the active ingredients
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/16—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/40—Liliopsida [monocotyledons]
- A01N65/42—Aloeaceae [Aloe family] or Liliaceae [Lily family], e.g. aloe, veratrum, onion, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/22—Phase substances, e.g. smokes, aerosols or sprayed or atomised substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2209/00—Aspects relating to disinfection, sterilisation or deodorisation of air
- A61L2209/10—Apparatus features
- A61L2209/13—Dispensing or storing means for active compounds
- A61L2209/134—Distributing means, e.g. baffles, valves, manifolds, nozzles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2209/00—Aspects relating to disinfection, sterilisation or deodorisation of air
- A61L2209/20—Method-related aspects
- A61L2209/21—Use of chemical compounds for treating air or the like
Abstract
Disclosed herein are disinfectant compositions comprising silver ion water and aloe vera juice or gel wherein the composition comprises a concentration of silver ion (Ag+) from about 0.04-2 ppm, and aloe vera juice or gel from 5-20% wt/wt of the total disinfectant composition, and wherein the silver ion water constitutes 60-90% wt/wt of the total disinfectant composition. Also disclosed are methods for the use of the non-biological surfaces comprising applying to the surface the compositions of the invention. The disinfectant compositions possesses useful surface disinfectant qualities, particularly against bacteria including staphylococcus aureus and MRSA. ion water constitutes 60-90% wt/wt of the total disinfectant composition. Also disclosed are methods for the use of the non-biological surfaces comprising applying to the surface the compositions of the invention. The disinfectant compositions possesses useful surface disinfectant qualities, particularly against bacteria including staphylococcus aureus and MRSA.
Description
DISINFECTANT COMPOSITIONS AND USES THEREOF
Field
The present invention relates generally to disinfectant compositions and methods for their
use and preparation thereof. In particular, the invention relates to chemical compositions
with useful surface disinfectant qualities against potentially harmful bacteria, algae, fungi,
and/or viruses.
Background
Staphylococcus aureus is a facultative anaerobic gram-positive coccal bacterium. It is the
most common species of Staphylococci to cause "Staph" infections. The primary reason
for this is that the careotenoid pigment staphloxanthin (r esponsible for its generic name
"golden staph") acts as a virulence factor, having an antioxidant action which aids in the
microbes evasion of death by the reactive oxygen species used by a host species immune
system.
Staphylococcus aureus can cause a range of illnesses from minor skin infections to life-
threatening diseases such as pneumonia, meningitis, osteomyelitis, endocarditis, toxic
shock syndrome, bacteremia, and sepsis. This typically results from skin, soft tissue,
respiratory, bone, joint, endovascular to wound infections. It is one of the five most
common causes of nosocomial infections, often causing postsurgical wound infections.
Each year, over a million patients in first-world hospitals contract a staphylococcal
infection.
Methicillin-resistant Staphylococcus aureus ('MRSA') is one of a number of virulent
strains of Staphylococcus aureus which have become resistant to most antibiotics. MRSA
strains are most often found associated with medical institutions such as hospitals, but are
becoming increasingly prevalent in community-acquired infections, such as in consumable
meat and poultry products.
The spread of Staphylococcus aureus (i ncluding MRSA) is generally thought to be through
human-to-human contact. Emphasis on basic hand washing techniques can go some of the
way in preventing its transmission. The use of disposable aprons and gloves by staff
reduces skin-to-skin contact and, therefore, further reduces the risk of transmission. It is
thought that the pathogen's transportation in medical facilities is mainly the results of
insufficient healthcare worker hygiene. For instance, the bacteria may be transported on
the hands of healthcare workers many of whom pick up the bacteria from seemingly
healthy patients carrying a benign or commensal strain of Staphylococcus aureus, or from
contaminated surfaces which is then passed on to the next patient being treated.
Staphylococcus aureus is an incredibly hardy bacterium, as was shown in a study where it
survived on polyester for just under three months. Ethanol and isopropanol have proven to
be effective immediate disinfectants against MRSA. However ethanol as a sanitizer or
disinfectant can be quite transient due to its relatively high vapour pressure. Also, being
flammable, it is not desirable to keep large amounts of ethanol in storage. Furthermore,
alcohols do not provide effective residual or persistent disinfectant activity.
The minimisation or prevention of nosocmial infections involves routine and terminal
cleaning. It is a current need to provide disinfectant compositions which are less volatile
and have longer duration (i ncreased persistence time/residual effect).
Summary of Invention
In one aspect the invention provides a disinfectant composition comprising an effective
amount of silver ion water and aloe vera juice or gel.
In an embodiment the disinfectant composition is in the form of a sprayable liquid.
In an embodiment the disinfectant composition is present in a disinfectant wipe.
In a further aspect the invention provides a method of disinfecting a substrate surface
comprising applying to said surface a disinfectant composition comprising an effective
amount of silver ion water and aloe vera juice or gel.
In an embodiment the method is conducted for the purpose of disinfecting a surface against
a bacteria, algae, fungi, and/or virus.
In an embodiment the bacteria, algae, fungi, and/or virus is selected from the group
consisting of Staphylococcus aureus (i ncluding MRSA), Escherichia coli (E . Coli),
Pseudomonas, Proteus vulgaris, Salmonella choleraesuis, Clostridium difficile, and
Enterococcus (i ncluding Vancomycin – resistant enterococci (V RE)) .
In an embodiment the method is conducted for the purpose of disinfecting a surface against
a bacteria, and in particular Staphylococcus aureus or MRSA.
Description of Preferred Embodiments
As used herein the term "disinfectant" refers to a substance that is applied to a non-
living/non-biological object (and in particular, a substrate surface) to destroy
microorganisms or viruses that may be present on the object. In the context of the present
invention the substance is a composition which comprises silver ion water and aloe vera
juice or gel. It will be appreciated that in the context of the present invention the term
"disinfectant" may also encompass the concept of sanitization, as the compositions of the
present invention may also serve to disinfect and clean. Without being bound to any
particular mode of action the compositions of the present invention may also, in some
embodiments, be classed as biocides in the context of being able to destroy viruses, in
addition to microorganism such as bacteria. In relation to this latter embodiment the
compositions may be thought as antibacterial disinfectants.
It will be appreciated that an "effective amount" as used herein refers to an amount of the
composition which is applied to a surface to disinfect the surface against viruses (e x vivo),
bacteria, algae, or fungi. Disinfection is readily achieved where the number of
microorganisms killed is a Log reduction of at least 4.0 which means that less than 1
microorganism in 10,000 remains. The compositions of the present invention may provide
Log reductions of at least 4.0, preferably at least 5.0, and more preferably at least about
6.0.
"Silver ion water" as used herein refers to an aqueous solution of silver ions which is
formed by disposing a silver rod electrode into an aqueous medium (typically just water)
and applying a voltage to the electrode rod and electrolysing. Apparatus for generating
silver ion water are known and are described for instance, in .
In a preferred embodiment the concentration of silver ions (A g ) in the water is about 0.02-
ppm, such as about 0.03-20 ppm, about 0.04-10 ppm, about 0.04-2 ppm, about 0.04-1
ppm, about 0.04-0.8 ppm, about 0.04-0.50 ppm, about 0.04-0.2 ppm, about 0.04-0.1 ppm,
and about 0.1 ppm.
The silver ion water typically constitutes from about 60-90 % wt/wt of the total
disinfectant composition. For instance, in certain embodiments the silver ion water
constitutes from about 70-90% wt/wt, about 75-85% wt/wt and preferably about 80-85%
wt/wt of the total disinfectant composition.
As used herein the term "aloe vera juice or gel" refers to an aloe vera liquid extract derived
from the leaf of an Aloe plant and typically, Aloe barbadensis or Aloe aborescens. Most
often the extracts are derived from the inner colourless parenchyma containing the aloe
gel, often referred to as the "inner pulp", "mucilage tissue", "mucilaginous gel",
"mucilaginous jelly", inner gel or leaf parenchyma tissue. Typically reference to "gel" or
"mucilage" refers to the clear viscous liquid within the parenchyma cells. Aloe vera juice
or gel is readily available commercially. For instance, a 99.9% Aloe Vera Juice
comprising stabilizers is available from Aloe Vera of Australia
( ht tp://www.aloevera.com.au).
The aloe vera juice or gel typically constitutes from about 5-20% wt/wt of the total
disinfectant composition. For instance, in some embodiments the aloe vera juice or gel
constitutes from about 7-15 % wt/wt, about 9-13 % wt/wt, about 10-13% wt/wt or about 12
% wt/wt of the total disinfectant composition.
Aloe vera gel typically has a viscosity ( m easured at 25 °C) of from about 80,000-900,000
cps, for instance, about 90,000-800,000 cps or about 100,000-700,000 cps. Aloe vera juice
is typically characterised with a viscosity (m easured at 25 °C) of from about 7 to 100 cps.
In an embodiment the disinfectant composition comprises about 80-85% wt/wt of silver
ion water and from about 10-13% wt/wt of aloe vera juice or gel.
In a particular embodiment the composition comprises silver ion water and aloe vera juice.
In another embodiment the composition comprises silver ion water with a Ag
concentration of 0.04 – 10 ppm, and preferably 0.04 – 2 ppm, and aloe vera juice.
In another embodiment the composition comprises silver ion water with a Ag
concentration of 0.04 – 10 ppm, and preferably 0.04 – 2 ppm, in an amount of 60-90%
wt/wt of the total disinfectant composition and aloe vera juice.
In another embodiment the composition comprises silver ion water with a Ag
concentration of 0.04 – 10 ppm, and preferably 0.04 – 0.2 ppm, in an amount of 60-90%
wt/wt of the total disinfectant composition and aloe vera juice in an amount of 5-20%
wt/wt of the total disinfectant composition.
The disinfectant composition of the present invention may include additional ingredients
such as acids (e.g., hydrochloric acid, sulphuric acid, etc); bases ( e.g., sodium hydroxide,
sodium carbonate, etc); surfactants (e .g., labs acid/laurylbenzene sulfonic acid, CTAB,
cocodiethanolamide (C DE, or CD80), SLES or sodium laureth sulfate, soap noodles,
glycols, etc); other disinfecting agents (e .g., formaldehyde (o r other aldehydes), ethanol or
isopropyl alcohol (o r other alcohols), sodium hypochlorite ( or other hypochlorites),
glycols, chloroamine, hydrogen peroxide, chlorine dioxide, permanganates, peracetic acid,
performic acid, phenol (and other phenolics), and quartenary ammonium compounds such
as benzalkonium chloride, etc); fragrances; antioxidants; phosphates (e .g., sodium
tripolyphosphate (S TPP)) and colouring agents.
In an embodiment the compositions of the present invention are phosphate free.
In an embodiment the compositions of the present invention are chlorine free. That is, the
compositions of the invention do not include sodium hypochlorite (o r other hypochlorites),
chloroamine, chlorine dioxide, and the like.
In an embodiment the composition is phosphate free and chlorine free.
In an embodiment any additional components in the specification do not constitute more
than 15 % wt/wt, of the total disinfectant composition. Typically, when present, the
additional components comprise between about 5-10 % wt/wt of the total disinfectant
composition.
In an embodiment the pH of the disinfectant composition is 8-11, more preferably 9-11,
and most preferably about 10.
In an embodiment the disinfectant composition is in the form of a sprayable liquid which
may be applied to a substrate by way of a hand-actuated or pressurised spray delivery
device (e .g., spray gun). In this regard, it is preferable that the viscosity of the composition
in the form of a sprayable liquid is from 1 to 5 cps (m easured at 25 °C).
In another embodiment the disinfectant composition may be first absorbed by an applicator
device (e.g., mob, cloth, cotton bud, paint brush, etc) a nd applied to a substrate.
In an embodiment the disinfectant composition is provided in the form of a disinfectant
wipe.
The wipe may improve the compositions performance by providing mechanical/physical
cleaning properties. The wipes of the invention comprise an absorbent substrate, for
instance, an absorbent nonwoven water insoluble substrate, which has been impregnated
with the disinfectant composition. The wipe may take the form of a towellette, cloth,
sheet, pad, or sponge and may also be associated with a holder device or applicator device
such as a handle. The impregnation step involves contacting the wipe with the
composition, for instance, by spraying or immersing the wipe with the composition for a
time and under conditions sufficient to allow for the wipe to be impregnated with the
composition.
In an embodiment the wipe is a nonwoven water insoluble material (subs trate) which is
synthetic or of plant origin. Such materials include rayon, polyester, nylon, polyethylene,
cotton, or cardboard.
The substrate for the wipes may be impregnated with the disinfecting composition at the
loading level from about 1.5 times the original weight of the wipe to about 10 times the
original weight of the wipe, preferably from about 2.5 times to about 7.5 times, and more
preferably from about 3 times to about 6 times.
The composition of the present invention may be applied to any substrate which may come
into contact with a microorganism or virus, such as in a hospital setting. Accordingly,
contemplated substrates include plastics/polymer surfaces (e.g., polyesters, PVC, etc),
stainless steel, wood, glass, laminates, ceramic, and so on.
In relation to the disinfectant qualities the present composition may be suitable for
disinfecting a surface against the following: methicillin resistant staphylococcus aureus
(i ncluding MRSA), staphylococcus aureus, human coronavirus, influenza A, listeria
monocytogenus, herpes simplex virus type 1, escherichia coli ( E . coli), acinetobacter
baumannii, vancomycin resistant enterococcus faecium (V RE), bacillus cereus, klebsiella
pneumoniae, rotavirus, human immunodeficient virus type 1, pseudomonas aeruginosa,
norovirus, salmonella choteraesuis, Clostridium difficile, rhinovirus, and trichophyton
mentagrophytes (A thlete's foot fungi).
In an embodiment the bacteria, algae, fungi, and/or virus is selected from the group
consisting of Staphylococcus aureus (i ncluding MRSA), Escherichia coli ( E . Coli),
Pseudomonas, Proteus vulgaris, Salmonella choleraesuis, Clostridium difficile, and
Enterococcus (i ncluding Vancomycin – resistant enterococci (V RE)) .
Preferably the disinfectant qualities of the composition are suitable for disinfecting a
surface against a gram-positive bacteria, preferably clostridium, Enterococcus, or
Staphylococcus.
Preferably the disinfectant qualities of the composition are suitable for disinfecting a
surface against a gram-negative bacteria, preferably Escherichia, Pseudomonas, Proteus
vulgaris, and Salmonella.
Preferably the disinfectant qualities of the composition are suitable for disinfecting a
surface against a bacteria, and preferably staphylococcus aureus and MRSA.
The antibacterial and antimicrobial nature of the silver ion (A g ) has been previously
reported. It is thought that when silver ions come into contact with a microbe they bind to
the cell membrane proteins' active site via thio groups. This in turn appears to cause a
malfunctioning of the membrane (a nd membrane production) allowing more silver ions to
penetrate the microbe which eventually dies due to cell lysis and/or cessation of metabolic
functioning of membrane proteins.
Without wishing to be bound by theory it is believed that the aloe vera juice or gel
enhances the persistence or residence time of this action on the surface by acting as a
carrier and delivery system for the active silver ions. Tests performed by the present
inventor suggest that the relatively hydrophobic nature of some of the components
(possi bly polymer components) in the aloe vera juice or gel aids in the composition's
ability to adhere and persist on a substrate surface even after being washed with water.
This is thought to facilitate increased microbe / Ag interaction which is beneficial in terms
of a longer lasting disinfectant effect. For instance, the residual efficacy of the disinfectant
qualities of the present invention could be as long as 2 to 5 days. In surgical suites it is
typically mandatory to disinfect after each surgical procedure. Due to human error it is not
always the case that an acceptable microbe free environment can be maintained between
surgical procedures. With a longer lasting persistence time the chances of not having a
microbe free surface between procedures is reduced. That is, if a surface is initially
disinfected but due to human error is not re-disinfected for 24-48 hours, the chances of this
surface harbouring concerning levels of dangerous microbes will be reduced with the
present composition. Thus while also being beneficial in terms of maintaining a
significantly longer lasting microbe free surface, the present compositions may also be
beneficial in terms of minimising the continued need to disinfect and re-disinfect a surface.
For instance, with traditional disinfectants it is often necessary to disinfect everyday to
maintain an effectively clean (i .e., microbe free) s urface. By using the present composition
a microbe free (or substantially microbe free) environment could be accomplished with
disinfecting every other day.
As a further advantage it is believed that the aloe vera, while acting as a carrier to maintain
Ag concentration on a surface for longer, may also provide an additive or synergistic
antibacterial effect. For instance, it has been reported that some of the constituents of aloe
vera juice or gel including lupeol, cinnamic acid, phenols (e .g., anthraquinones), and
saponins, may provide antimicrobial benefits.
In an embodiment the composition provides a Log reduction of at least 4.0 for 24-48 hrs.
In an embodiment the composition provides a Log reduction of at least 4.0 for about 48
hrs.
In an embodiment the composition provides a Log reduction of at least 4.0 for about 48-72
hrs.
In another embodiment the composition provides a Log reduction of at least 4.0 for 24-72
hrs.
In a further embodiment the composition provides a Log reduction of at least 4.0 for 24-96
hrs.
In a further embodiment the composition provides a Log reduction of at least 4.0 for 24-
120 hrs.
Those skilled in the art will appreciate that the invention described herein in susceptible to
variations and modifications other than those specifically described. It is to be understood
that the invention includes all such variations and modifications which fall within the spirit
and scope. The invention also includes all of the steps, features, compositions and
compounds referred to or indicated in this specification, individually or collectively, and
any and all combinations of any two or more of said steps or features.
The reference in this specification to any prior publication ( or information derived from it),
or to any matter which is known, is not, and should not be taken as an acknowledgment or
admission or any form of suggestion that that prior publication (or information derived
from it) or known matter forms part of the common general knowledge in the field of
endeavour to which this specification relates.
Throughout this specification and the claims which follow, unless the context requires
otherwise, the word "comprise", and variations such as "comprises" and "comprising", will
be understood to imply the inclusion of a stated integer or step or group of integers or steps
but not the exclusion of any other integer or step or group of integers or steps.
Certain embodiments of the invention will now be described with reference to the
following examples which are intended for the purpose of illustration only and are not
intended to limit the scope of the generality hereinbefore described.
Examples
1. Disinfectant Compositions
a) Phosphate based formulation
Material Name Amount
Silver Ion Water (0.1 ppm) 815.32 L
Sodium Hydroxide 1.07 Kg
STPP, Sodium Tripolyphosphate 18.02 Kg
Sodium Carbonate, Dense Soda Ash 9.01 Kg
Labs Acid 8.11 Kg
CDE 80, Decolamide, Coco
0.52 Kg
Diethanolamine
SLES, Chemsalan, Genapol LRO Paste 2.10 Kg
Butyl Di Glycol S.G. 95 27.03 Kg
Formaldehyde 2.00 Kg
Rhodomine ACID Dye 0.90 g
Fragrance Rain Forest 0.90 Kg
Aloe Vera Juice 99.10 Kg
Water Hot 9.01 L
Soap Noodles 1.25 Kg
b) Phosphate-free formulation
Material Name Amount
Silver Ion Water (0.1 pp m) 815.32 L
Sodium Hydroxide 1.07 Kg
Sodium Carbonate, Dense Soda Ash 9.01 Kg
Material Name Amount
Labs Acid 8.11 Kg
CDE 80, Decolamide, Coco
0.52 Kg
Diethanolamine
SLES, Chemsalan, Genapol LRO Paste 2.10 Kg
Butyl Di Glycol S.G. 95 27.03 Kg
Formaldehyde 2.00 Kg
Rhodomine ACID Dye 0.90 g
Fragrance Rain Forest 0.90 Kg
Aloe Vera Juice 99.10 Kg
Water Hot 9.01 L
Soap Noodles 1.25 Kg
General Formulation Methodology for formulations a) or b)
SILVER ION WATER is added to a tank. While mixing, SODIUM HYDROXIDE, STPP
( opt ional) and SODIUM CARBONATE are added and mixed until dissolved. While still
mixing, LABS ACID and CDE are added, SLES and BUTYL DIGLYCOL are premixed
and then also added to the tank. FORMALDEHYDE, DYE, and LITSEA CUBEBA
(f ragrance) are then also added to the tank. SOAP NOODLES are dissolved in 1 litre of
HOT WATER (a s hot as possible) and added to the tank and mixed. The ALOE VERA
JUICE is then added. The pH of the formulation is 10.
2. Disinfectant Testing – substrate based
a) General Method
The antimicrobial activity of composition 1a was tested using the JIS methodology JIS Z
2801:2000(E ) conducted by Micromon (Mona sh University) – Melbourne Australia (A BN
12377614012)
Provided was three test pieces and six control pieces of a substrate 50 mm × 50 mm.
According to the standard, each control and test piece for all three samples were cleaned
by wiping lightly with 80% ethanol and then placed in individual sterile Petri dishes.
Composition 1a was then applied to three test pieces. For analysis of the immediate effect
of 1a, each test piece and six control pieces were then inoculated with 0.4 mL of a culture
of Staphylococcus aureus ATCC6538 that had been adjusted by dilution to approximately
2.5 × 10 cells per mL.
The inoculum was covered with a film measuring 40 x 40 mm and the film pressed to
spread the inoculum over the entire surface area of the sample covered by the film. The lid
was then placed on the Petri dish. The Petri dishes containing three control pieces and
three test pieces for each sample were then incubated at 35°C (r elative humidity of
approximately 90%) for 24 hours. The three remaining Petri dishes containing control
pieces from each sample were processed immediately to determine the base line viable
count.
To test the viable number of bacterial cells present from each of the control pieces, both
prior to and following incubation, and the test pieces, 10 ml of SCDLP broth was added to
the Petri dishes containing the pieces, and the Petri dish was then shaken for 10 minutes on
an orbital shaker. Following this, 1 mL of the washings was taken from each test and
control piece and diluted in sterile physiological saline. One mL aliquots of various
dilutions were added to duplicate 15 mL of molten plate count agar and mixed thoroughly.
The plate count agar was then poured into sterile Petri dishes and allowed to set. Plates
were then incubated at 35°C ( r elative humidity of approximately 90%) for 40 hours.
Following incubation the number of colonies present on each plate were recorded and a
viable count calculated.
b) Results
1. On Laminate
The results recorded from these plates are given in the tables below:
Table 1: Viable Counts for samples when Staphylococcus aureus was used as an
inoculum
Viable Count (c fu/ml)
Composition 1a Composition 1a
Cleaner T Cleaner T
0 24
Prior to Incubation:
Control 1 1.41 × 10 4.10 × 106
Control 2 1.52 × 10 2.65 × 106
Control 3 1.46 × 10 4.50 × 106
Post Incubation:
Control 4 1.14 × 10 5.00 × 102
Control 5 3.02 × 10 1.17 × 103
Control 6 1.50 × 10 5,65 × 105
Post Incubation:
Test 1 <10 <10
Test 2 <10 <10
Test 3 55 <10
An average of the viable counts for the three controls were taken prior to incubation, the
three controls post incubation, and the three test pieces for each of the samples.
This data is presented in the tables below:
Table 2: Average viable counts for pre and post incubation controls and test
pieces when Staphylococcus aureus was used as an inoculum.
Average Viable Count (c fu/ml)
Composition 1a Composition 1a
Cleaner T Cleaner T
0 24
Prior to Incubation
1.46 × 10 3.75 × 106
Untreated Controls
Post Incubation:
1.89 × 10 1.89 × 105
Untreated Controls
Post Incubation:
10
Treated Test Pieces
The efficiency of each of the tests was determined using the following formula based on
the results reported in the above tables:
(L - L )/ ( L ) ≤ 0.2
max min mean
Where:
L : maximum logarithm of the number of viable cells of bacteria immediately
following inoculation on untreated test pieces.
L : minimum logarithm of the number of viable cells of bacteria immediately
following inoculation on untreated test pieces.
mean : average logarithm of the number of viable cells of bacteria immediately
following inoculation on untreated test pieces.
The test was judged as being effective when the above equation was satisfied.
Logarithmic values of the number of viable cells of bacteria immediately following
inoculation on the untreated test pieces are reported in the tables below:
Table 3: Logarithms for untreated samples following inoculation when
Staphylococcus aureus was used as an inoculum
Logarithmic value of viable cells
Composition 1a Composition 1a
Cleaner T Cleaner T
0 24
Prior to Incubation:
Control 1 7015 ( L ) 6.61
Control 2 7.18 (L ) 6.42 (L )
max min
Control 3 7.16 6.65 (L )
L 7.16 6.56
mean
0.003 0.035
(L - L ) / (L )
max min mean
Based on the above data all tests were determined to be effective as the equation was
satisfied in each instance.
The value of the antimicrobial activity was then calculated for each test using the
following equation:
R = [log(B /A)-log( C /A)] =[log (B/C)]
Where:
R : value of antimicrobial activity
A : average of the number of viable cells of bacteria immediately after inoculation
on the untreated test pieces
B : average of the number of viable cells of bacteria on the untreated test piece after
24 hours
C : average of the number of viable cells of bacteria on the treated test piece after
24 hours
Higher numbers for the value of R indicate better antimicrobial activity. The values of R,
A, B and C are recorded in the following tables:
Table 4: Values of R, A, B and C when Staphylococcus aureus was used as an
inoculum
Average Viable Count (c fu/ml)
Composition 1a Composition 1a
Cleaner T Cleaner T
0 24
Prior to Incubation
Untreated Controls 1.46 × 10 3.75 ×10
Post Incubation:
Untreated Controls 1.89 × 10 1.89 ×10
Post Incubation:
Treated Test Pieces 25 10
Antimicrobial
4.9 4.3
Activity [R]
>99.99% >99.99%
% Reduction
(> 4.0 log ) ( > 4.0 log )
10
Comments:
The tests conducted were deemed to be effective as dictated by standard JIS Z
2801:2000(E ).
As is indicated by the positive values for Antimicrobial Activity [R] the product, 1a, has
significant antimicrobial activity against Staphylococcus aureus when tested on laminate.
This level of activity (> 3 for Antimicrobial Activity, and >99.9% for the % Reduction) is
categorized as strong activity. Further, this level of activity was retained even when the
product had been applied 24 hours previous to the challenge with the bacteria.
2. On Stainless Steel
The results recorded from these plates are given in the tables below:
Table 5: Viable Counts for samples when Staphylococcus aureus was used as an
inoculum
Viable Count (c fu/ml)
Composition 1a Composition 1a
Cleaner T Cleaner T
0 24
Prior to Incubation:
Control 1 1.32 × 10 4.30 × 10
Control 2 1.94 × 10 4.90 × 10
Control 3 1.39 × 10 4.70 × 10
Post Incubation:
Control 4 7.00 × 10 5.45 × 10
Control 5 5.95 × 10 7.65 × 10
Control 6 1.04 × 10 9.95 × 10
Post Incubation:
Test 1 8.15 × 10 1.99 × 10
Test 2 <10 2.29 × 10
Test 3 7.35 × 10 1.48 × 10
We then took an average of the viable counts for the three controls prior to incubation, the
three controls post incubation, and the three test pieces for each of the samples.
This data is presented in the tables below:
Table 6: Average viable counts for pre and post incubation controls and test
pieces when Staphylococcus aureus was used as an inoculum
Average Viable Count (c fu/ml)
Composition 1a Composition 1a
Cleaner T Cleaner T
0 24
Prior to Incubation
1.55 × 10 4.63 × 106
Untreated Controls
Post Incubation:
2.57 × 10 7.68 × 106
Untreated Controls
Post Incubation:
2.72 × 10 1.92 × 106
Treated Test Pieces
The efficiency of each of the tests was determined using the following formula based on
the results reported in the above tables:
(L – L ) / (L ) ≤ 0.2
max min mean
Where:
max : maximum logarithm of the number of viable cells of bacteria immediately
following inoculation on untreated test pieces.
L : minimum logarithm of the number of viable cells of bacteria immediately
following inoculation on untreated test pieces.
L : average logarithm of the number of viable cells of bacteria immediately
mean
following inoculation on untreated test pieces.
The test was judged as being effective when the above equation was satisfied.
Logarithmic values of the number of viable cells of bacteria immediately following
inoculation on the untreated test pieces are reported in the tables below:
Table 7: Logarithms for untreated samples following inoculation when S. aureus
was used as an inoculum
Logarithmic value of viable cells
Composition 1a Composition 1a
Cleaner T Cleaner T
0 24
Prior to Incubation:
Control 1 6.12 ( L ) 6.63 ( L )
min min
Control 2 6.29 ( L ) 6.69 (L )
max max
Control 3 6.14 6.67
L 6.18 6.66
mean
0.03 0.009
(L - L )/ (L )
max min mean
Based on the above data all tests were determined to be effective as the equation was
satisfied in each instance.
The value of the antimicrobial activity was then calculated for each test using the
following equation:
R = [log(B /A)-log(C /A)] =[log (B/C)]
Where:
R : value of antimicrobial activity
A : average of the number of viable cells of bacteria immediately after inoculation
on the untreated test pieces
B : average of the number of viable cells of bacteria on the untreated test piece after
24 hours
C : average of the number of viable cells of bacteria on the treated test piece after
24 hours
Higher numbers for the value of R indicate better antimicrobial activity. The values of R,
A, B and C are recorded in the following tables:
Table 8: Values of R, A, B and C when Staphylococcus. aureus was used as an
inoculum
Average Viable Count (c fu/ml)
Composition 1a Composition 1a
Cleaner T Cleaner T
0 24
Prior to Incubation
Untreated Controls 1.55 × 10 4.63 × 106
Post Incubation:
Untreated Controls 2.57 × 10 7.68 × 106
Post Incubation:
Treated Test Pieces 2.72 × 10 1.92 × 106
Antimicrobial
0.97 0.60
Activity [R]
% Reduction 89.42% 75.00%
Comments:
The tests conducted were deemed to be effective as dictated by standard JIS Z
2801:2000(E ).
As is indicated by the positive values for Antimicrobial Activity [R] the product, 1a, has
some level of antimicrobial activity against Staphylococcus aureus when tested on
stainless steel.
It is worth noting that the product, when applied to stainless steel produces a surfactant-
like quality, which makes it difficult to retain the bacterial test sample on the surface of the
test piece. The activity reported here may in actual fact be much more significant, as it is
possible that the bacteria were able to escape killing because they may have "slipped" off
the test piece during the 24 incubation step.
- 23 –
Claims (20)
1. A disinfectant composition comprising an effective amount of silver ion water and aloe vera juice or gel, wherein the composition comprises a concentration of silver ion 5 (A g ) from about 0.04-2 ppm, and aloe vera juice or gel from 5-20% wt/wt of the total disinfectant composition, and wherein the silver ion water constitutes 60-90% wt/wt of the total disinfectant composition.
2. A disinfectant composition according to claim 1 wherein the disinfectant 10 composition is in the form of a sprayable liquid.
3. A disinfectant composition according to claim 1 wherein the disinfectant composition is impregnated into a wipe. 15
4. A disinfectant composition according to any one of claims 1 to 3 wherein the composition is phosphate free.
5. A disinfectant composition according to any one of claims 1 to 3 wherein the composition is chloride free.
6. A disinfectant composition according to any one of claims 1 to 3 wherein the composition is phosphate and chloride free.
7. A disinfectant composition according to any one of claims 1 to 6 comprising Aloe 25 Vera juice.
8. A disinfectant composition according to any one of claims 1 to 7 wherein the pH of the composition is about 9-11. 30
9. A disinfectant composition according to claim 8 wherein the pH of the composition is about 10. - 24 –
10. A method of disinfecting a substrate surface comprising applying to said surface (non -biological) a disinfectant composition according to any one of claims 1-9. 5
11. A method according to claim 10 for disinfecting a surface against a bacteria, algae, fungi, and/or virus selected from the group consisting of Staphylococcus aureus (i ncluding MRSA), Escherichia coli (E . Coli), Pseudomonas, Proteus vulgaris, Salmonella choleraesuis, Clostridium difficile, and Enterococcus (i ncluding Vancomycin - resistant enterococci (V RE) ).
12. A method according to claim 11 for disinfecting a surface against a bacteria, and preferably Staphylococcus aureus or MRSA.
13. A method according to claim 11 for disinfecting a surface against E. Coli.
14. A method according to claim 11 for disinfecting a surface against Pseudomonas.
15. A method according to claim 11 for disinfecting a surface against Proteus vulgaris. 20
16. A method according to claim 11 for disinfecting a surface against Salmonella choleraesuis.
17. A method according to claim 11 for disinfecting a surface against Clostridium difficile.
18. A method according to claim 11 for disinfecting a surface against VRE.
19. A method according to any one of claims 10 to 18 wherein the substrate is selected from the group consisting of plastics/polymers, stainless steel, wool, glass. laminates and 30 ceramics. - 25 –
20. A method according to any one of claims 10 to 12 wherein the composition provides a Log reduction of at least 4.0 for about 48-72 hrs in relation to Staphylococcus aureus or MRSA.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2011903807 | 2011-09-16 | ||
AU2011903807A AU2011903807A0 (en) | 2011-09-16 | Disinfectant Compositions and Uses Thereof | |
PCT/AU2012/001117 WO2013037014A1 (en) | 2011-09-16 | 2012-09-17 | Disinfectant compositions and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ622781A NZ622781A (en) | 2015-03-27 |
NZ622781B2 true NZ622781B2 (en) | 2015-06-30 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2884060C (en) | A prolonged disinfectant composition for non-biological surfaces comprising silver ion water and aloe vera | |
EP2424352B1 (en) | Methods and composition for treating a material | |
US6921745B2 (en) | Bactericidal composition comprising polylysine and a plant essential oil | |
EP2040540B1 (en) | Basic compositions comprising an alkanol and a fatty acid salt or a fatty acid glyceride for sanitising a material | |
Oule et al. | Akwaton, polyhexamethylene-guanidine hydrochloride-based sporicidal disinfectant: a novel tool to fight bacterial spores and nosocomial infections | |
US8785621B2 (en) | Method for disinfecting surfaces | |
EP2965624A1 (en) | Concentrate for a disinfectant, disinfectant and process for disinfecting a surface | |
US11279902B2 (en) | Hyperprotonation cleaning, disinfection, and sterilization compositions and methods | |
EP0609106A1 (en) | A glutaraldehyde composition | |
CN110477792A (en) | A kind of nonalcoholic wet tissue and preparation method thereof can be used for breathing mask cleaning-sterilizing | |
US6462088B1 (en) | Disinfecting preparation containing chlorine in alcohol | |
NZ622781B2 (en) | Disinfectant compositions and uses thereof | |
JPH07252105A (en) | Liquid disinfectant | |
Y Bashandy et al. | Efficacy of a novel foot pan in biosecurity protocols for control of salmonellae in poultry farms | |
Eissa et al. | Study of antimicrobial power of amphoteric disinfectants of Tego series used in pharmaceutical industry | |
CN108064847A (en) | Bactericidal composition with improved antimicrobial efficacy | |
Samson-Enitan et al. | Assessment of the bacteriological quality and efficacy of two hand sanitizers sold within Ilishan-Remo Community of Ogun State, Nigeria | |
de Carvalho et al. | Genipa americana fruit ethanolic extract in the control of environmental infecting agents | |
NO347094B1 (en) | Method for elimination of microorganisms | |
CN115969826A (en) | Skin disinfectant and method for disinfecting skin | |
FPV et al. | GUIDELINE for Disinfectant choice in feline veterinary hospitals, shelters and cat households | |
Taiwo et al. | The use of disinfectants in medical and health related Institutions: An Overview |